Key result
ECT combined with amantadine and ziprasidone yields marked catatonia improvement in a pediatric schizophrenia case.
Why the study?
Does electroconvulsive therapy improve catatonic symptoms in an adolescent patient with schizophrenia?
Case Report (n=1)
Does electroconvulsive therapy improve catatonic symptoms in an adolescent patient with schizophrenia?
Electroconvulsive therapy can be beneficial in the treatment of catatonic symptoms in adolescent patients with schizophrenia.
ECT may aid refractory adolescent catatonia; leaves open controlled confirmation in schizophrenia.
This article presents a case of a 14-year-old female twin with schizophrenia who developed severe catatonia following treatment with olanzapine. Under a combined treatment with amantadine, electroconvulsive therapy (ECT), and (currently) ziprasidone alone she improved markedly. Severity and course of catatonia including treatment response were evaluated with the Bush-Francis Catatonia Rating Scale (BFCRS). This case report emphasizes the benefit of ECT in the treatment of catatonic symptoms in an adolescent patient with schizophrenic illness.
No takes yet. Share an insight, caveat, or question.
Häßler et al. (2012) conducted a case report in Schizophrenia with severe catatonia (n=1). Electroconvulsive therapy (ECT) combined with amantadine and ziprasidone was evaluated on Severity and course of catatonia evaluated with the Bush-Francis Catatonia Rating Scale (BFCRS). Electroconvulsive therapy (ECT) combined with amantadine and ziprasidone led to marked improvement of severe catatonia in a 14-year-old girl with schizophrenia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: